只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-06 2026-07-08 | LMND Lemonade, Inc. | Peters John Sheldon Officer · Chief Insurance Officer | 卖出（S） | 3,444 | US$79.00 | US$272,076.00 | 77,942 | SEC |
| 2026-07-06 2026-07-07 | MIAX MIAMI INTERNATIONAL HOLDINGS, INC. | Brown Shelly Officer · EVP, Chief Strategy Officer | 卖出（S） | 16,000 | US$42.13 | US$674,080.00 | 353,990 | SEC |
| 2026-07-01 2026-07-06 | ALXO ALX ONCOLOGY HOLDINGS INC | Wong Shelly Officer · SVP, FINANCE AND CAO | 卖出（S） | 1,404 | US$2.04 | US$2,864.16 | 88,401 | SEC |
| 2026-07-01 2026-07-02 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 6,500 | US$87.52 | US$568,880.00 | 1,834 | SEC |
| 2026-07-01 2026-07-02 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 1,834 | US$88.34 | US$162,015.56 | 0 | SEC |
| 2026-06-17 2026-06-18 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L. Director,Officer · President and CEO | 卖出（S） | 53,588 | US$3.16 | US$169,338.08 | 2,119,111 | SEC |
| 2026-06-17 2026-06-17 | SOFI SoFi Technologies, Inc. | Rishel Jeremy Officer · Chief Technology Officer | 卖出（S） | 102,123 | US$17.78 | US$181.57万 | 895,089.44 | SEC |
| 2026-06-15 2026-06-17 | MIAX MIAMI INTERNATIONAL HOLDINGS, INC. | Brown Shelly Officer · EVP, Chief Strategy Officer | 卖出（S） | 4,714 | US$44.23 | US$208,500.22 | 316,714 | SEC |
| 2026-06-12 2026-06-15 | SNPS SYNOPSYS INC | Glaser Shelagh Officer · CFO | 卖出（S） | 3,394 | US$450.02 | US$152.74万 | 14,358 | SEC |
| 2026-06-04 2026-06-05 | LMND Lemonade, Inc. | Peters John Sheldon Officer · Chief Insurance Officer | 卖出（S） | 3,608 | US$52.94 | US$191,007.52 | 81,386 | SEC |
| 2026-06-03 2026-06-05 | LMND Lemonade, Inc. | Peters John Sheldon Officer · Chief Insurance Officer | 卖出（S） | 1,735 | US$53.17 | US$92,249.95 | 84,994 | SEC |
| 2026-06-03 2026-06-03 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 8,333 | US$75.00 | US$624,975.00 | 0 | SEC |
| 2026-06-02 2026-06-04 | MIAX MIAMI INTERNATIONAL HOLDINGS, INC. | Brown Shelly Officer · EVP, Chief Strategy Officer | 卖出（S） | 16,000 | US$42.12 | US$673,920.00 | 325,047 | SEC |
| 2026-05-21 2026-05-26 | AMZN AMAZON COM INC | Reynolds Shelley Officer · Vice President | 卖出（S） | 1,600 | US$261.83 | US$418,928.00 | 120,543 | SEC |
| 2026-05-21 2026-05-26 | AMZN AMAZON COM INC | Reynolds Shelley Officer · Vice President | 卖出（S） | 300 | US$263.99 | US$79,197.00 | 119,780 | SEC |
| 2026-05-21 2026-05-26 | AMZN AMAZON COM INC | Reynolds Shelley Officer · Vice President | 卖出（S） | 463 | US$263.25 | US$121,884.75 | 120,080 | SEC |
| 2026-05-21 2026-05-22 | BWB Bridgewater Bancshares Inc | Shellberg Jeffrey D. Director | 卖出（S） | 20,000 | US$18.55 | US$371,000.00 | 25,000 | SEC |
| 2026-05-19 2026-06-09 | TWN TAIWAN FUND INC | Rigger Shelley E Director | 卖出（S） | 134 | US$88.82 | US$11,901.88 | 166 | SEC |
| 2026-05-19 2026-05-20 | NHC NATIONAL HEALTHCARE CORP | Shelly Timothy J. Officer · Sr.VP Operations | 卖出（S） | 1,853 | US$197.22 | US$365,448.66 | 1,294 | SEC |
| 2026-05-18 2026-05-20 | OKTA Okta, Inc. | ARCHAMBEAU SHELLYE L Director | 卖出（S） | 2,500 | US$85.00 | US$212,500.00 | 9,192 | SEC |
| 2026-05-11 2026-05-13 | HURN Huron Consulting Group Inc. | Singh-Bushell Ekta Director | 卖出（S） | 443 | US$118.44 | US$52,468.92 | 13,646 | SEC |
| 2026-05-11 2026-05-11 | ODTX Odyssey Therapeutics, Inc. | Chu Shelley Director | 买入（P） | 11,111 | US$18.00 | US$199,998.00 | 11,111 | SEC |
| 2026-05-08 2026-05-12 | MTRN MATERION Corp | Chadwick Shelly Marie Officer · Vice President, Finance & CFO | 卖出（S） | 1,192 | US$198.88 | US$237,064.96 | 15,246 | SEC |
| 2026-05-07 2026-05-08 | BWB Bridgewater Bancshares Inc | Shellberg Jeffrey D. Director | 卖出（S） | 8,174 | US$18.45 | US$150,810.30 | 45,000 | SEC |
| 2026-05-06 2026-05-08 | BWB Bridgewater Bancshares Inc | Shellberg Jeffrey D. Director | 卖出（S） | 9,252 | US$18.45 | US$170,699.40 | 53,174 | SEC |
| 2026-05-06 2026-05-08 | SNDR Schneider National, Inc. | Dumas Magnin Shelly A Officer · VP and Corporate Controller | 卖出（S） | 2,425 | US$30.90 | US$74,932.50 | 24,697 | SEC |
| 2026-05-04 2026-05-05 | MIAX MIAMI INTERNATIONAL HOLDINGS, INC. | Brown Shelly Officer · EVP, Chief Strategy Officer | 卖出（S） | 16,000 | US$47.28 | US$756,480.00 | 325,047 | SEC |
| 2026-05-01 2026-05-05 | BWB Bridgewater Bancshares Inc | Shellberg Jeffrey D. Director | 卖出（S） | 62 | US$18.50 | US$1,147.00 | 62,426 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 5,059 | US$74.60 | US$377,401.40 | 400 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 10,358 | US$73.74 | US$763,798.92 | 5,459 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 12,777 | US$72.94 | US$931,954.38 | 15,817 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 8,777 | US$71.56 | US$628,082.12 | 28,594 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 19,656 | US$70.61 | US$138.79万 | 37,371 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 400 | US$75.37 | US$30,148.00 | 0 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 21,306 | US$69.53 | US$148.14万 | 57,027 | SEC |
| 2026-04-29 2026-05-01 | BWB Bridgewater Bancshares Inc | Shellberg Jeffrey D. Director | 卖出（S） | 2,512 | US$18.50 | US$46,472.00 | 62,488 | SEC |
| 2026-04-08 2026-04-09 | MIAX MIAMI INTERNATIONAL HOLDINGS, INC. | Brown Shelly Officer · EVP, Chief Strategy Officer | 卖出（S） | 16,434 | US$42.08 | US$691,542.72 | 325,047 | SEC |
| 2026-04-07 2026-04-09 | MIAX MIAMI INTERNATIONAL HOLDINGS, INC. | Brown Shelly Officer · EVP, Chief Strategy Officer | 卖出（S） | 900 | US$42.00 | US$37,800.00 | 325,047 | SEC |
| 2026-04-07 2026-04-08 | MIAX MIAMI INTERNATIONAL HOLDINGS, INC. | Brown Shelly Officer · EVP, Chief Strategy Officer | 卖出（S） | 900 | US$42.00 | US$37,800.00 | 324,147 | SEC |
| 2026-04-06 2026-04-09 | MIAX MIAMI INTERNATIONAL HOLDINGS, INC. | Brown Shelly Officer · EVP, Chief Strategy Officer | 卖出（S） | 2,357 | US$41.33 | US$97,414.81 | 325,047 | SEC |
| 2026-04-06 2026-04-08 | MIAX MIAMI INTERNATIONAL HOLDINGS, INC. | Brown Shelly Officer · EVP, Chief Strategy Officer | 卖出（S） | 2,357 | US$41.33 | US$97,414.81 | 325,047 | SEC |
| 2026-04-02 2026-04-06 | HURN Huron Consulting Group Inc. | Singh-Bushell Ekta Director | 卖出（S） | 126 | US$126.93 | US$15,993.18 | 14,089 | SEC |
| 2026-04-01 2026-04-03 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 7,958 | US$50.00 | US$397,900.00 | 0 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| SHEL | 678,994.4181 | 1,553 | 2,444,653.5057 | 27.77% | B, Q, N |